Atanu Bhattacharjee
Brigham and Women's Hospital(US)Harvard University(US)University of Leicester(GB)University of Dundee(GB)Bangladesh University(BD)National Institute of Technology Agartala(IN)Ramakrishna Mission Vidyamandira(IN)Leicester General Hospital(GB)Ramakrishna Mission Vivekananda Educational and Research Institute(IN)Calcutta Research Group(IN)Translational Research in Oncology(FR)AstraZeneca (India)(IN)Genomics (United Kingdom)(GB)NIHR Leicester Biomedical Research Centre(GB)Gautam Buddha University(IN)Global University(LB)St Xavier’s College(IN)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Statistical Methods and Inference, Statistical Methods in Clinical Trials, Lung Cancer Treatments and Mutations, Statistical Methods and Bayesian Inference
Most-Cited Works
- → Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer(2019)416 cited
- → Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial(2017)328 cited
- → Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study(2022)187 cited
- → Isolation and Characterisation of Mesenchymal Stem Cells from Different Regions of the Human Umbilical Cord(2013)158 cited
- → A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer(2019)128 cited
- → Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial